SYMBIOTEC — Symbiotec Pharmalab Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹74.81bn
- IN₹78.41bn
- IN₹17.38bn
Annual cashflow statement for Symbiotec Pharmalab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 383 | 1,310 | 1,470 | 1,534 |
| Depreciation | ||||
| Non-Cash Items | 50.8 | 23 | 188 | 321 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -26.4 | 154 | -1,616 | -642 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 1,385 | 3,750 | 945 | 3,492 |
| Capital Expenditures | -2,244 | -2,098 | -3,081 | -2,257 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 44 | 33.6 | 16 | -12.1 |
| Sale of Fixed Assets | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -4,400 | -4,128 | -6,130 | -4,539 |
| Financing Cash Flow Items | -70.8 | -73.2 | -156 | -264 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 2,923 | 437 | 5,563 | 720 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -46.1 | 29.4 | 189 | -164 |